Last update:
Oncology news
Commonly used cancer drugs shown to boost MRSA antibiotics
Scientists at University of Galway have uncovered a link between commonly used anticancer drugs and antibiotics that could offer a new approach to tackling superbug infections. The research team set out to find new ways to ...
41 minutes ago
0
0
Dual-drug approach burns out leukemia cells by pressing accelerator and brake simultaneously
Pushing the accelerator and the brake at the same time is rarely a good idea. But researchers at the University of Gothenburg are using this approach to treat leukemia. A new drug forces cancer cells to keep working hard ...
4 hours ago
0
1
Vitamin A metabolite keeps immune cells active against recurrent brain tumors
Immune cells can become exhausted after prolonged exposure to cancer, gradually losing their ability to attack tumor cells. This phenomenon is particularly pronounced in aggressive brain tumors and can severely limit the ...
3 hours ago
0
1
Can removing fallopian tubes really reduce the risk of ovarian cancer?
Ovarian cancer has a particularly poor survival rate. Only one in two women will live five years beyond their diagnosis. There is no effective screening test, and symptoms can be hard to spot. This means ovarian cancer is ...
5 hours ago
0
0
Children with cancer are being saved, but are we breaking them in the process?
Survival rates for childhood cancer now exceed 80%—but this also means more children are living with the long-term emotional and psychosocial impacts of cancer.
6 hours ago
0
1
Patient questionnaires may add a new layer to chronic lymphocytic leukemia prognosis
Patients' responses to questions routinely raised by oncologists may provide important clues about their chances of survival from chronic lymphocytic leukemia (CLL), according to a new study published in the journal Therapeutic ...
15 hours ago
0
4
New tool measures thyroid cancer patients' anxiety
A new tool created by Cedars-Sinai Health Sciences University investigators is the first to measure anxiety in patients with thyroid cancer. Described in the journal Thyroid, the Thyroid Cancer Modified Anxiety Scale (TC-MAX) ...
21 hours ago
0
7
Understudied gut fungus may help repair radiation-damaged DNA and limit intestinal injury
The gut microbiome has been a popular topic for a while now, but the focus is usually on good bacteria. A new study, published in the journal Proceedings of the National Academy of Sciences, suggests that we may want to pay ...
Reducing unnecessary fluid testing could lower cancer care costs
Doctors might be able to safely reduce health care costs by skipping unnecessary laboratory tests for patients with advanced gynecologic cancers, according to a Cedars-Sinai Health Sciences University study. The paper, published ...
Sep 7, 2026
0
3
How losing the 'guardian of the genome' can damage DNA and drive cancer
A new study finds that when p53, one of the most important cancer-protecting genes, stops working, cells produce too much RNA and consume excessive amounts of the building blocks needed to copy their DNA. This shortage disrupts ...
Sep 7, 2026
0
10
Bacteria that can make testosterone: What could that mean for prostate cancer?
Many prostate cancers depend on androgen hormones, including testosterone, to grow. That is why treatments for advanced disease often try to reduce testosterone production or block its effects. Now, scientists have identified ...
Sep 7, 2026
0
14
Brain's inhibitory circuits emerge as a potential brake on adult glioma progression
Brain tumors do not grow in isolation. They develop within the highly active environment of the brain, where neurons continuously exchange electrical and chemical signals. While previous studies have shown that neuronal activity ...
Sep 7, 2026
0
4
Trial: Prostate cancer fitness cuts treatment side effects
Findings from STAMINA, the largest trial of its kind, published in The Lancet Oncology, show that a purpose-designed lifestyle program offering structured exercise, dietary advice and behavioral support as part of routine ...
Sep 7, 2026
0
21
Focal therapy use remains uncommon in nonmetastatic prostate cancer
For patients with nonmetastatic prostate cancer, focal therapy use has remained uncommon across risk groups, and its use was defined as inappropriate in about half of recipients, according to a research letter published online ...
Sep 6, 2026
0
114
Targeting cell division protein CDK2 could boost immunotherapy response across a wide range of cancers
New research from Dana-Farber Cancer Institute scientists suggests that cyclin-dependent kinase 2 (CDK2) inhibitors, which are currently being tested as treatments that slow the growth of a narrow range of cancers, could ...
Sep 5, 2026
0
15
Rethinking radiotherapy may boost immunotherapy for pancreatic cancer
Pancreatic cancer remains one of the most aggressive malignancies, with a particularly poor prognosis even when diagnosed at a localized stage. In a paper published in Nature Reviews Gastroenterology & Hepatology, researchers ...
Sep 4, 2026
0
71
AI may help identify breast cancers missed by mammograms, but clinical benefit remains uncertain
Artificial intelligence may help radiologists identify subtle signs of breast cancers that are missed during routine mammograms, and some AI systems may even identify patterns associated with an increased risk of cancer before ...
Sep 4, 2026
0
22
Tumor biology could guide mantle cell lymphoma treatment from the time of diagnosis
Today, treatment decisions for patients with mantle cell lymphoma are heavily based on age alone, although the disease can range from slow-growing (indolent) to very aggressive. In a new journal article, Ingrid Glimelius ...
Sep 4, 2026
0
4
People affected by cancer need a stronger voice in shaping generative AI for oncology, review finds
Flinders University researchers were part of an international team that conducted a scoping review that identified 2,441 records and found that just 32 studies examined how cancer patients, survivors and caregivers feel about ...
Sep 4, 2026
0
8
FDA approves first-in-class drug for polycythemia vera
The U.S. Food and Drug Administration has approved Takeda Pharmaceuticals' Mimrylo (rusfertide) as a new treatment for adults with polycythemia vera who have not achieved adequate control with existing therapies.
Sep 4, 2026
0
9
Cancer cells release antioxidants to prevent immune cells from destroying them
Molecules called reactive oxygen species, which include so-called "free radicals," have long been viewed as damaging byproducts of our body's metabolism—a reason antioxidant supplements have been considered a potential way ...
Sep 3, 2026
0
283
Psilocybin prevents chemotherapy-related nerve injury and associated symptoms in preclinical models
In a breakthrough study, researchers at The University of Texas MD Anderson Cancer Center discovered that psilocybin given before chemotherapy prevented the onset of nerve injury in preclinical models, even after repeated ...
Sep 3, 2026
0
132
Microdroplets may reduce colorectal tumor growth at potentially lower cost
Scientists from Nanyang Technological University, Singapore (NTU Singapore) have developed microscopic peptide droplets that deliver large amounts of gene-silencing molecules into cancer and immune cells, reducing the growth ...
Sep 3, 2026
0
6
Patients diagnosed with lung cancer found to have more microplastic in their lungs
People with lung cancer are more likely to have microplastics in their lungs and to have larger quantities of microplastics in their lungs, according to research that will be presented at the European Respiratory Society ...
Sep 3, 2026
0
8
